Did Alvotech's (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative? [Yahoo! Finance]
Alvotech (ALVO)
Company Research
Source: Yahoo! Finance
updates on FDA feedback, global biosimilar launches, and new commercialization agreements. The combination of returning to profitability, advancing a 30-product biosimilar pipeline, and reaffirming 2026 guidance highlights a business model becoming more diversified across products, partners, and regions. We'll now examine how Alvotech's return to profitability and strengthened biosimilar pipeline reshape its investment narrative and future risk-reward balance. The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation. Alvotech Investment Narrative Recap To own Alvotech, you need to believe in its ability to convert a broad biosimilar pipeline and partner network into durable, profitable cash flows. The latest swing to a 2025 net profit of US$27.92 million supports that case, but the main near term catalyst remains U.S. FDA approvals, where complete response letters and inspection fi
Show less
Read more
Impact Snapshot
Event Time:
ALVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALVO alerts
High impacting Alvotech news events
Weekly update
A roundup of the hottest topics
ALVO
News
- Alvotech (ALVO) had its price target lowered by UBS Group AG from $10.00 to $6.00. They now have a "buy" rating on the stock.MarketBeat
- Alvotech (ALVO) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "underweight" rating on the stock.MarketBeat
- Alvotech (ALVO) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Alvotech (ALVO) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Alvotech Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
ALVO
Earnings
- 11/12/25 - Beat
ALVO
Sec Filings
- 3/19/26 - Form 6-K
- 3/12/26 - Form SCHEDULE
- 2/27/26 - Form 6-K
- ALVO's page on the SEC website